Tirzepatide emerges a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://aronoamu339285.blogthisbiz.com/48173729/tirzepatide-a-new-frontier-in-diabetes-treatment